Day One Biopharmaceuticals
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
About Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages. The company understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. They develop new therapies that meet the critical needs of people of all ages living with cancer, starting from the biology of childhood cancer.
Company Facts
- Headquarters
- South San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00101_00250
- Funding Stage
- ipo
- Total Funding
- $687,500,000
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2024-07-30
- Website
- dayonebio.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/day-one-biopharmaceuticals-48638 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.